Arock M - Search Results

1

A new therapeutic advance for symptomatic systemic mastocytosis?

Arock M. Arock M. Lancet. 2017 Feb 11;389(10069):576-578. doi: 10.1016/S0140-6736(16)31655-5. Epub 2017 Jan 7. Lancet. 2017. PMID: 28069280 No abstract available.

2

Tripe palms associated with systemic mastocytosis: the role of transforming growth factor-alpha and efficacy of interferon-alfa.

Chosidow O, Bécherel PA, Piette JC, Arock M, Debré P, Francès C. Chosidow O, et al. Among authors: arock m. Br J Dermatol. 1998 Apr;138(4):698-703. doi: 10.1046/j.1365-2133.1998.02190.x. Br J Dermatol. 1998. PMID: 9640384

3

c-Kit and c-kit mutations in mastocytosis and other hematological diseases.

Boissan M, Feger F, Guillosson JJ, Arock M. Boissan M, et al. Among authors: arock m. J Leukoc Biol. 2000 Feb;67(2):135-48. doi: 10.1002/jlb.67.2.135. J Leukoc Biol. 2000. PMID: 10670573 Review.

4

Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts.

Féger F, Ribadeau Dumas A, Leriche L, Valent P, Arock M. Féger F, et al. Among authors: arock m. Int Arch Allergy Immunol. 2002 Feb;127(2):110-4. doi: 10.1159/000048179. Int Arch Allergy Immunol. 2002. PMID: 11919418 Review.

5

Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms.

Zermati Y, De Sepulveda P, Féger F, Létard S, Kersual J, Castéran N, Gorochov G, Dy M, Ribadeau Dumas A, Dorgham K, Parizot C, Bieche Y, Vidaud M, Lortholary O, Arock M, Hermine O, Dubreuil P. Zermati Y, et al. Among authors: arock m. Oncogene. 2003 Feb 6;22(5):660-4. doi: 10.1038/sj.onc.1206120. Oncogene. 2003. PMID: 12569358

6

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria.

Valent P, Akin C, Sperr WR, Escribano L, Arock M, Horny HP, Bennett JM, Metcalfe DD. Valent P, et al. Among authors: arock m. Leuk Res. 2003 Jul;27(7):635-41. doi: 10.1016/s0145-2126(02)00168-6. Leuk Res. 2003. PMID: 12681363 Review.

7

Diagnosis and treatment of systemic mastocytosis: state of the art.

Valent P, Akin C, Sperr WR, Horny HP, Arock M, Lechner K, Bennett JM, Metcalfe DD. Valent P, et al. Among authors: arock m. Br J Haematol. 2003 Sep;122(5):695-717. doi: 10.1046/j.1365-2141.2003.04575.x. Br J Haematol. 2003. PMID: 12930381 Review. No abstract available.

8

[Mastocytosis: advances in molecular diagnosis and therapeutics].

Arock M. Arock M. Ann Pharm Fr. 2004 Jul;62(4):233-43. doi: 10.1016/s0003-4509(04)94307-6. Ann Pharm Fr. 2004. PMID: 15243341 Review. French.

9

[Mastocytosis, classification, biological diagnosis and therapy].

Arock M. Arock M. Ann Biol Clin (Paris). 2004 Nov-Dec;62(6):657-69. Ann Biol Clin (Paris). 2004. PMID: 15563424 Review. French.

10

The European Competence Network on Mastocytosis (ECNM).

Valent P, Arock M, Bischoff SC, Bühring HJ, Brockow K, Escribano L, Födinger M, Grabbe J, Hartmann K, Henz BM, Horny HP, Kluin-Nelemans HC, Lima M, Marone G, Orfao A, Parwaresch RM, Sillaber C, Sotlar K, Sperr WR, Triggiani M, Van Doormaal JJ, Wolff K, Zuberbier T. Valent P, et al. Among authors: arock m. Wien Klin Wochenschr. 2004 Oct 30;116(19-20):647-51. doi: 10.1007/s00508-004-0253-3. Wien Klin Wochenschr. 2004. PMID: 15941072

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results